Primus III

Primus III was an early-stage venture capital fund launched in 2010 by Primus Capital Partners, based in Budapest, Hungary. The fund focused on investing in technology-enabled services, commercial services, and companies within the technology, media, and telecommunications (TMT) sectors. Primus III aimed to support 10 to 12 companies, with a preference for investments of up to EUR 1.5 million. This approach allowed the fund to engage with promising enterprises in Hungary, providing them with the necessary capital to fuel their growth and development. Primus Capital Partners, founded in 2003, has a broader investment strategy that includes sectors such as healthcare, pharmaceuticals, and biotechnology, emphasizing partnerships with innovative companies to realize their business potential.

Creighton Aldridge

Associate

Istvan Alpek

Partner & CFO

Danny Carpenter

VP

Michael Coletti

Associate

Bruce Crabtree IV

Vice President

Aaron Davis

Director

Jonathan Dick

Managing Director

Carlos Eyzaguirre

Associate

Helen Gao

Associate

John Grayson

Senior Associate

Ron Hess

Managing Director

Ronald Hess Jr.

Managing Director

Vikas Kottamasu

Associate

Phillip C. Molner II

Managing Partner

Aliraza Momin

Associate

William C. Mulligan

Managing Director

Connor Murphy

Associate

Dominic Offredo

CFO, CCO

Scott W. Seelbach

Director

Chandler Watlington

Vice President

Christopher Welch

Director

Loyal Wilson

Managing Partner

Diana Yang

Associate

Past deals in Hungary

Maven7

Seed Round in 2014
Maven7 supports business decisions by transforming large amounts of hard-to-interpret data into actionable business intelligence. Based on the methodologies of network analysis and data mining, Maven7 has developed its own proprietary network mapping tools, including OrgMapper and Diktio Labs, to conduct analyses in organizational development, social media, the pharmaceutical/medical industries and many other fields.

iCatapult

Series A in 2012
iCatapult is a specialized accelerator which provides lean development methodology and experiential global startup know-how by experienced mentors in the acceleration phase and global business development and market access functions in the rollout phase. iCatapult exclusively focuses on CEE startups and technologies with global technologies (or technologies which has the potential to become global).

CloudAgents

Venture Round in 2010
CloudAgents is a global leader in providing multilingual contact center services using an at-home workforce. The company provides OmniChannel Front Office BPO services globally with more than 12,000 Native Speakers in 150+ languages. The company’s cloud-based systems and patent pending processes enable it to employ and manage its workforce remotely, which includes home-based agents. The model provides the ability for companies and organizations to reach out and cater their customers globally in any language, while provides the ability for people to work wherever and whenever they want. Since its foundation in 2008, CloudAgents has handled over 20 million customer interactions and executed more than 500 projects for more than 250 blue chip clients in multiple languages. Company has chosen as Top 100 Tech Companies in Europe by Red Herring in 2015.

Intellio

Venture Round in 2009
Intellio is a privately held technology company developing a new generation of advanced video surveillance systems. Started in 2004 by a group of software and hardware engineers from the security industry. The Intellio system is designed especially for medium and large, multi-site surveillance environments. By automating the recognition of an increasing number of events posing a security risk the Intellio system is designed to enable security providers to take immediate action in case of potential and actual risk-events.

NEBOTRADE

Venture Round in 2005
NEBOTRADE, Ltd. is a Hungarian company established in 1993, specializing in the development and manufacturing of microbiological media. With a production facility that began operations in 1996, the company is capable of producing up to 200,000 kilograms of culture media annually, with batch sizes ranging from 25 to 5,000 kilograms. NEBOTRADE offers a diverse portfolio of over 200 products, catering to various sectors, including medical and veterinary bacteriology, food microbiology, industrial applications, and mycology. The company also produces transport media and is equipped to manufacture customized cell culture solutions tailored to client specifications. NEBOTRADE serves the pharmaceutical industry, leveraging its skilled technical staff to meet the specific demands of its customers.